Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker

被引：0
|
作者：
Kiran Kumar Jagarlamudi
Lars Olof Hansson
Staffan Eriksson
机构：
[1] Swedish University of Agricultural Sciences,Department of Anatomy, Physiology, and Biochemistry, Veterinary Medicine and Animal Science center
[2] Department of Laboratory Medicine,undefined
[3] Karolinska Institute,undefined
来源：
BMC Cancer | / 15卷
关键词：
Serum thymidine kinase 1; STK1 protein assays; Size exclusion chromatography; Anti-human TK1 antibodies; TK1 specific activity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 24 条
  • [1] Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker
    Jagarlamudi, Kiran Kumar
    Hansson, Lars Olof
    Eriksson, Staffan
    BMC CANCER, 2015, 15
  • [2] Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker
    Jagarlamudi, Kiran Kumar
    Westberg, Sara
    Ronnberg, Henrik
    Eriksson, Staffan
    BMC VETERINARY RESEARCH, 2014, 10
  • [3] Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker
    Kiran Kumar Jagarlamudi
    Sara Westberg
    Henrik Rönnberg
    Staffan Eriksson
    BMC Veterinary Research, 10
  • [4] Elevated thymidine kinase 1 (TK1) in cancer serum may suppress immune function.
    Smith, Kathryn R.
    Morris, Rachel M.
    Velazquez, Edwin J.
    Bellini, David M.
    O'Neill, Kim
    CANCER RESEARCH, 2021, 81 (13)
  • [5] Serum Concentration of Thymidine Kinase 1 (TK1) as a Tumor Marker in Soft Tissue Sarcomas
    Jaamaa, Sari
    Nevala, Riikka
    Jagarlamudi, Kiran
    Tukiainen, Erkki
    Blomqvist, Carl
    Sampo, Mika
    ANTICANCER RESEARCH, 2022, 42 (03) : 1509 - 1515
  • [6] Clinical significance of serum thymidine kinase 1 (TK1) expression in patients with non-small cell lung cancer
    Bi, Ming-Hong
    Han, Wei
    Liu, Jing-Jing
    Wang, Hong-Ya
    Gao, Zhen-Yuan
    Tian, Wan-Lin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (05): : 8536 - 8542
  • [7] Immunohistochemistry for Thymidine Kinase-1 (TK1): A Potential Tool for the Prognostic Stratification of Breast Cancer Patients
    Fanelli, Giuseppe Nicolo
    Scarpitta, Rosa
    Cinacchi, Paola
    Fuochi, Beatrice
    Szumera-Cieckiewicz, Anna
    De Ieso, Katia
    Ferrari, Paola
    Fontana, Andrea
    Miccoli, Mario
    Naccarato, Antonio Giuseppe
    Scatena, Cristian
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (22)
  • [8] Measuring TK1 autoantibodies in the serum of cancer and non-cancer patients
    LaPorte, Wesley
    Abegg-Lawrence, Taylor
    Alegre, Melissa M.
    Robison, Richard A.
    O'Neill, Kim L.
    CANCER RESEARCH, 2011, 71
  • [9] A NEW ASSAY MEASURING THYMIDINE KINASE (TK1) SERUM CONCENTRATIONS-COMPARISON WITH THE DIASORIN TK-LIAISON ACTIVITY ASSAY
    Cooray, Ruby
    Venge, P.
    Larsson, R.
    Eriksson, S.
    TUMOR BIOLOGY, 2010, 31 : S82 - S83
  • [10] Prognostic significance of serum thymidine kinase activity (TK1) level in patients with metastatic non-small cell lung cancer (NSCLC)
    Korkmaz, T.
    Seber, S.
    Basaran, G.
    Yumuk, P. F.
    Dane, F.
    Okutur, K.
    Kanitez, M.
    Kocar, M.
    Telli, F.
    Demir, G.
    Turhal, N. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
123